Open AccessP1067: PHASE 2 STUDY OF ORAL THALIDOMIDE‐CYCLOPHOSPHAMIDE‐DEXAMETHASONE FOR RECURRENT/REFRACTORY ADULT LANGERHANS CELL HISTIOCYTOSIS
Author(s) -
Wang J.N.,
Liu T.,
Zhao A.L.,
Pan B.J.,
Sun J.,
Li J.,
Zhou D.B.,
Duan M.H.,
Cao X.X.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847136.19477.8e
Subject(s) - langerhans cell histiocytosis , thalidomide , medicine , cyclophosphamide , regimen , dexamethasone , refractory (planetary science) , gastroenterology , surgery , clinical endpoint , salvage therapy , cytarabine , chemotherapy , clinical trial , multiple myeloma , disease , physics , astrobiology